APA (7th ed.) Citation

FL, H., C, D., R, E., ML, S., MP, F., C, S., . . . CC, C. (2025). Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. Theranostics, 15(13), 6444. https://doi.org/10.7150/thno.112588

Chicago Style (17th ed.) Citation

FL, Herr, et al. "Association of Integrated Biomarkers and Progression-free Survival Prediction in Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing [177Lu]Lu-DOTA-TATE Therapy." Theranostics 15, no. 13 (2025): 6444. https://doi.org/10.7150/thno.112588.

MLA (9th ed.) Citation

FL, Herr, et al. "Association of Integrated Biomarkers and Progression-free Survival Prediction in Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing [177Lu]Lu-DOTA-TATE Therapy." Theranostics, vol. 15, no. 13, 2025, p. 6444, https://doi.org/10.7150/thno.112588.